Where I see patients (1)
My reviews
Selected research
-
Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704.
Blood advances
-
Assessing cognitive function in transplantation and chimeric antigen receptor t cell therapy recipients: Expert recommendations from the survivorship, aging and biobehavioral special interest groups of the American Society for Transplantation and Cellular Therapy.
Transplantation and cellular therapy
-
Assessing physical function in transplantation and CAR-T recipients: expert recommendations from the survivorship, aging and biobehavioral special interest groups of ASTCT.
Transplantation and cellular therapy
Clinical trials
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
The feasibility of completing molecular, genetic, immunophenotypic, and biochemical testing for assignment of therapy will be assessed based on the proportion of patients for whom testing is completed within 7 days of the registra...
Recruiting
4.9